Luna Trading Co.pvt.ltd Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Luna Trading Co.pvt.ltd Pharmaceutical Import Records from India — 4 Products, $553.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Luna Trading Co.pvt.ltd — Pharmaceutical Importer Profile (2026) | 4 Products, $553.5K Trade | TransData Nexus

Luna Trading Co.pvt.ltd

Pharmaceutical Importer · Nepal · Ayurvedic & Herbal Products Focus · $553.5K Total Trade · DGFT Verified

Luna Trading Co.pvt.ltd is a pharmaceutical importer based in Nepal with a total trade value of $553.5K across 4 products in 1 therapeutic categories. Based on 415 verified import shipments from Indian Customs (DGFT) records, Luna Trading Co.pvt.ltd is the #1 buyer in 1 product including Arishta. Luna Trading Co.pvt.ltd sources from 1 verified Indian supplier, with Dabur India Limited accounting for 100.0% of imports.

Luna Trading Co.pvt.ltd — Import Portfolio & Supplier Network

Luna Trading Co.pvt.ltd import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Luna Trading Co.pvt.ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Dabur India Limited	$181.8K	198	100.0%

Luna Trading Co.pvt.ltd sources from 1 verified Indian supplier across 153 distinct formulations. The sourcing is highly concentrated — Dabur India Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Luna Trading Co.pvt.ltd Import?

Formulation	Value	Ships
Honitus syrup 100 ML	$18.2K	2
Dashmularishta 450 ML	$17.8K	3
Honitus syrup 100	$16.4K	2
Ashwagandharishta 450 ML	$6.7K	1
Vr vatchintamani ras gold 30 TAB	$6.1K	1
Yogenfra ras gold 10 TAB	$5.0K	1
Ashokarishta 450ML	$4.8K	1
Rasraj ras gold 10 TAB	$4.3K	1
Ras pipari 10 TAB	$4.2K	2
Dashmularishta 450 ML	$4.0K	3
Ashokarishta 450 ML	$3.8K	1
Basant kusumakar ras gold 30 TAB	$3.7K	1
Vr vatchintamani ras gold 10 TAB	$3.5K	1
Hingwastak churna 60GM	$3.0K	1
Brahmi bati 40 TAB	$3.0K	3

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Arishta	Ayurvedic & Herbal Products	$463.9K	199	29.4%	1
2	Asava	Ayurvedic & Herbal Products	$50.4K	102	9.4%	2
3	Gutika	Ayurvedic & Herbal Products	$27.1K	59	15.8%	2
4	Bhasma	Ayurvedic & Herbal Products	$12.0K	55	2.9%	8

Luna Trading Co.pvt.ltd imports 4 pharmaceutical products across 1 categories into Nepal totaling $553.5K. The company is the #1 buyer for 1 product: Arishta.

Luna Trading Co.pvt.ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Luna Trading Co. Pvt. Ltd. is a pharmaceutical importer and buyer based in Nepal, specializing in the acquisition of finished pharmaceutical formulations from India. The company operates as a trader, facilitating the importation and distribution of various pharmaceutical products within Nepal. While specific details about its headquarters and parent company are not publicly disclosed, Luna Trading Co. Pvt. Ltd. plays a significant role in Nepal's pharmaceutical supply chain by sourcing a diverse range of products to meet the country's healthcare needs.

2Distribution Network

The available data does not provide specific information regarding Luna Trading Co. Pvt. Ltd.'s warehouse locations, logistics capabilities, or geographic coverage within Nepal. However, given the company's substantial import volume and product diversity, it is reasonable to infer that it maintains a robust distribution network to effectively supply the domestic market. The absence of detailed logistics information suggests that the company may operate through partnerships with local distributors or utilize third-party logistics providers to manage its supply chain operations.

3Industry Role

Luna Trading Co. Pvt. Ltd. functions primarily as a pharmaceutical importer and distributor within Nepal's healthcare sector. By sourcing finished pharmaceutical formulations from India, the company ensures a steady supply of essential medicines to meet domestic demand. Its role is crucial in bridging the gap between international pharmaceutical manufacturers and the local market, thereby contributing to the accessibility and availability of a wide range of pharmaceutical products in Nepal.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Luna Trading Co.pvt.ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Luna Trading Co. Pvt. Ltd. demonstrates a high level of supplier concentration, sourcing all its pharmaceutical imports from a single supplier, Dabur India Limited. This exclusive sourcing strategy indicates a strong and stable relationship between the two entities, potentially leading to favorable terms and consistent product quality. However, such dependency also poses risks; any disruptions in Dabur India's operations—such as production issues, regulatory challenges, or logistical problems—could significantly impact Luna Trading Co. Pvt. Ltd.'s ability to meet market demand. The company's reliance on a single supplier underscores the importance of maintaining a robust and resilient supply chain to mitigate potential risks associated with supplier dependency.

2Supply Chain Resilience

The resilience of Luna Trading Co. Pvt. Ltd.'s supply chain is closely tied to the stability and reliability of Dabur India Limited. Given the exclusive sourcing arrangement, the company may face challenges in diversifying its supplier base, which could limit its ability to adapt to market changes or disruptions. Additionally, the absence of information regarding backup suppliers or alternative sourcing strategies suggests a potential vulnerability in the supply chain. To enhance resilience, Luna Trading Co. Pvt. Ltd. might consider exploring partnerships with additional suppliers or developing contingency plans to address potential disruptions in the supply chain.

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

In Nepal, the pharmaceutical industry is regulated by the Department of Drug Administration (DDA), which operates under the Ministry of Health and Population. The DDA is responsible for overseeing the production, marketing, import, export, storage, supply, sale, and distribution of medicines and health technologies. The primary legislation governing pharmaceuticals in Nepal is the Drug Act 2035 (1978), which establishes the legal framework for drug regulation, including the registration of pharmaceutical products and the licensing of manufacturers and importers. The DDA enforces compliance with this act and formulates policies to ensure the safety, efficacy, and quality of pharmaceutical products in the country.

2Import Licensing & GMP

To import pharmaceutical products into Nepal, companies must obtain an import license from the DDA. The requirements for obtaining this license include company registration, possession of a valid PAN/VAT, storage facilities with temperature control, and the appointment of a qualified pharmacist. Each imported medicine must also be registered with the DDA, ensuring that all pharmaceutical products meet the prescribed safety, efficacy, and quality standards. Additionally, the DDA conducts inspections to verify compliance with Good Manufacturing Practice (GMP) standards, which are mandatory for all pharmaceutical products imported into Nepal.

Luna Trading Co.pvt.ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Luna Trading Co. Pvt. Ltd. focuses on importing Ayurvedic and herbal products, with a particular emphasis on formulations such as Arishta, Asava, Gutika, and Bhasma. This strategic focus aligns with the growing demand for traditional medicine in Nepal, where Ayurvedic and herbal remedies are deeply rooted in the cultural and healthcare practices of the population. The company's product strategy is driven by market demand for natural and holistic treatment options, catering to consumers seeking alternatives to conventional pharmaceuticals.

2Sourcing Profile

Luna Trading Co. Pvt. Ltd. primarily sources generic drug formulations from India, focusing on Ayurvedic and herbal products. The company's sourcing strategy emphasizes the procurement of finished pharmaceutical formulations, ensuring that products are ready for distribution upon arrival in Nepal. India's well-established pharmaceutical industry, particularly in the production of Ayurvedic and herbal medicines, makes it a strategic partner for Luna Trading Co. Pvt. Ltd., enabling access to a wide range of products that meet the company's quality and regulatory standards.

3Market Positioning

Seller's Guide — How to Become a Supplier to Luna Trading Co.pvt.ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Luna Trading Co. Pvt. Ltd. by offering complementary Ayurvedic and herbal products that align with the company's existing portfolio. By introducing innovative formulations or unique product offerings, Indian exporters can help diversify Luna Trading Co. Pvt. Ltd.'s product range, reducing supply chain risks associated with single-source dependency. Additionally, suppliers can explore opportunities to provide products that cater to emerging consumer preferences, such as organic or sustainably sourced ingredients, thereby enhancing the company's market competitiveness.

2Requirements & Qualifications

Indian exporters seeking to supply Luna Trading Co. Pvt. Ltd. and the Nepalese market must ensure that their products are registered with the DDA and comply with GMP standards recognized by the DDA. Products should meet the quality, safety, and efficacy standards prescribed by the DDA, and labeling must be in the Nepali language, providing clear and accurate information about the product. Additionally, exporters should be prepared to provide necessary documentation, such as certificates of analysis, stability data, and manufacturing licenses, to facilitate the import and registration process in Nepal.

Frequently Asked Questions — Luna Trading Co.pvt.ltd

What products does Luna Trading Co.pvt.ltd import from India?

Luna Trading Co.pvt.ltd imports 4 pharmaceutical products across 1 categories. Top imports: Arishta ($463.9K), Asava ($50.4K), Gutika ($27.1K), Bhasma ($12.0K).

Who supplies pharmaceuticals to Luna Trading Co.pvt.ltd from India?

Luna Trading Co.pvt.ltd sources from 1 verified Indian suppliers. The primary supplier is Dabur India Limited (100.0% of imports, $181.8K).

What is Luna Trading Co.pvt.ltd's total pharmaceutical import value?

Luna Trading Co.pvt.ltd's total pharmaceutical import value from India is $553.5K, based on 415 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Luna Trading Co.pvt.ltd focus on?

Luna Trading Co.pvt.ltd imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Luna Trading Co.pvt.ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.